Study confirms GSK-Vir antibody drug reduces hospitalisation, death in Covid-19 patients | Malay Mail

  • 📰 malaymail
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 86%

Malaysia Headlines News

Malaysia Latest News,Malaysia Headlines

NEW YORK, June 21 — GlaxoSmithKline Plc and Vir Biotechnology said today final results from a late-stage study of their monoclonal antibody confirmed it significantly reduced hospitalisation and death among high-risk Covid-19 patients when given early in the disease. The treatment, sotrovimab,...

NEW YORK, June 21 — GlaxoSmithKline Plc and Vir Biotechnology said today final results from a late-stage study of their monoclonal antibody confirmed it significantly reduced hospitalisation and death among high-risk Covid-19 patients when given early in the disease.

The drugmakers also said today the US National Institutes of Health has recommended sotrovimab to treat high-risk, non-hospitalised patients with mild-to-moderate Covid-19-19. In a study of 1,057 patients, sotrovimab resulted in a 79 per cent reduction in risk of hospitalisation for more than 24 hours or death due to any cause, the companies said today.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 1. in MY

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study confirms GSK-Vir antibody drug reduces hospitalisation, death in Covid-19 patientsA study of more than 1,000 patients shows a 79 percent reduction in risk of hospitalisation.
Source: malaysiakini - 🏆 20. / 51 Read more »

Study confirms GSK-Vir antibody drug reduces hospitalization, death in Covid-19 patients | Malay MailNEW YORK, June 21 — GlaxoSmithKline Plc and Vir Biotechnology said today final results from a late-stage study of their monoclonal antibody confirmed it significantly reduced hospitalization and death among high-risk Covid-19 patients when given early in the disease. The treatment, sotrovimab,...
Source: malaymail - 🏆 1. / 86 Read more »

Study confirms GSK-Vir antibody drug axes Covid hospitalisation, deathsThe treatment also appears to 'retain activity' against variants of concern and interest. FMTNews
Source: fmtoday - 🏆 5. / 72 Read more »

22 new Covid-19 clusters today | The Malaysian Insight14 groupings linked to workplaces, seven community transmissions, one high-risk group.
Source: msianinsight - 🏆 8. / 63 Read more »

Covid-19 tests down 10.9%, positivity rate up 0.3% last week | The Malaysian InsightAn average of 80,165 screenings were conducted per day between June 13 and 19. they should do more testing with each passing day. but what happens? why bull talk about our testing capabilities if we only plan to utilise parts of the capabilities? it's like boasting of having a Ferrari then drive at 20km/h. ain't tht a kind of stupidity?
Source: msianinsight - 🏆 8. / 63 Read more »

Registrations in mosques, markets and house visits to boost Covid-19 vaccination drive | Malay MailKUALA LUMPUR, June 21 — “I am not afraid to get the vaccine shot, we all need to be vaccinated to protect ourselves and prevent others from getting infected,” said retired teacher Md Yusof Abdullah, 62, after attending the Ketereh Parliamentary Covid-19 Vaccination Tour Programme ‘Mari...
Source: malaymail - 🏆 1. / 86 Read more »